Riik: Austraalia
keel: inglise
Allikas: Department of Health (Therapeutic Goods Administration)
tadalafil, Quantity: 2.5 mg
Cipla Australia Pty Ltd
Tadalafil
Tablet, film coated
Excipient Ingredients: croscarmellose sodium; hyprolose; magnesium stearate; microcrystalline cellulose; lactose monohydrate; sodium lauryl sulfate; titanium dioxide; hypromellose; purified talc; triacetin; iron oxide yellow; iron oxide red
Oral
10, 28, 20, 7
(S4) Prescription Only Medicine
CIPLA TADALAFIL is indicated for the treatment of: ? erectile dysfunction (ED) in adult males ? moderate to severe lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) in adult males
Visual Identification: Cream coloured, circular, biconvex film coated tablet with "T 2.5" debossed on one side and plain on other side.; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius
Licence status A
2017-03-27